Topical Skin Adhesives Market Snapshot

Key Players

  • Johnson & Johnson (United States)
  • GlaxoSmithKline Plc (United Kingdom)
  • Medtronic Plc (Ireland)
  • 3M Company (United States)
  • Becton Dickinson and Company (United States)
  • Chemence Medical (United States)
  • Perrigo Pharmaceuticals Company (Ireland)
  • Medline Industries (United States)
  • Advanced Medical Solutions Group plc (United Kingdom)
  • Adhezion Biomedical (United States)

Market Size

Base Year 2024
$1.87 Bn
CAGR
7.36%
Forecast 2034
$3.80 Bn

Market Segments

By Chemistry
2-Octyl Cyanoacrylate, N-Butyl Cyanoacrylate, Others
By Application
Surgical Incisions, Traumatic Lacerations
By Product Form
Liquid, Gel
By Distribution Channel
Direct Sales, Distributors
By End User
Hospitals, Emergency Centers, Clinics

Market Dynamics

Drivers
  • Rising demand for non-surgical treatments
  • Increasing cosmetic surgery trends
Restraints
  • High cost of products
  • Risk of skin irritation
Opportunities
  • Rising cosmetic surgery procedures
  • Increasing minor surgeries

Market Size

The Topical Skin Adhesives Market valued at $2.01 billion in 2025, and it is projected to reach $3.80 billion by 2034, expanding at a CAGR of 7.36%. The market witnessed steady growth from $1.87 billion in 2024 to $2.01 billion in 2025. Driving this expansion are advanced surgical procedures demanding the usage of topical skin adhesives, increasing usage in wound closure applications, and the rising preference for minimally invasive techniques. Whereas, the regional share distribution in 2024 indicated, North America held the largest market share at 39.42%, followed by Asia Pacific at 28.86%, Europe at 24.36%, Latin America at 3.62%, and the Middle East and Africa at 3.74%.

Key Takeaways

  • By Chemistry - 2-Octyl Cyanoacrylate positioned itself as a revenue leader in 2024 due to its broad market adoption.
  • By Application - Traumatic Lacerations subsegment is poised to grow at the fastest rate during the forecasting period.
  • By Product Form - Gel segment is expected to record the fastest CAGR during the forecast period.
  • By Distribution Channel - Distributors accounted for the largest revenue share within the market in 2024.
  • By End User - Hospitals generated the largest revenue within this market.
topical-skin-adhesives-market market size

Key Driving Factors

Rising Prevalence of Trauma and Surgical Wounds

The rising incidences of trauma and surgical injuries globally are introducing a critical market trigger for the Topical Skin Adhesives Market. Major driver of the market were seen with affecting surgeons and medical practitioners in healthcare institutions. The demand for ensuring rapid, significant wound closure following surgical procedures or trauma events has become essential within the business. Topical skin adhesives serve as an efficient, non-invasive option to traditional wound closure techniques such as sutures or staples. This immediate demand and higher efficiency influences the purchase of topicals skin adhesives. Therefore, the need to maintain high-quality patient care standards and enhance healing process responses drives ongoing investment and consumption of these adhesive solutions, thus accelerating market demand in the healthcare sector.

Preference for Minimally Invasive Procedures

The global healthcare industry's growing preference towards minimally invasive procedures is another significant driving factor for the market. Influencing this trend are healthcare providers, including hospitals and clinics, aiming for reducing patient discomfort and recovery time. Hence, a shift towards the use of topical skin adhesives is witnessed as they are unable penetrating in the dermis layer of the skin. Their application reduces the postoperative care requirements and lessens the likelihood of scarring. This immediate need to enhance patient comfort and satisfaction levels has mandated investment into these solutions without deferral. Hence, the transition towards minimally invasive operations drives market demand for topical skin adhesives.

Market Evolution by Timeline

2019-2023
In this period, the topical skin adhesives market witnessed a growing demand from healthcare institutions driven by the need for non-invasive and cost-effective wound healing solutions. This was also the time when regulation, particularly the FDA's guidance on cyanoacrylate-based adhesives, influenced many purchasing decisions. Hospitals, in particular, emerged as key purchasers, especially in developed countries. In response, manufacturers focused on improving their formulation capabilities and achieving regulatory compliance. Suppliers began diversifying sources to reduce reliance on a single provider, and it was common to see long-term supply agreements between manufacturers and distributors.
2024
The year 2024 marked a significant shift in the topical skin adhesives market with a surge in purchases from home care settings and emerging markets. This was driven by growing awareness and acceptance of adhesives as a viable alternative to traditional sutures. For addressing this, manufacturers began tailoring their product portfolio to serve for consumer preferences, which often varied by region. They expanded manufacturing capacities to keep pace with rising demand while also aiming to meet stringent quality standards. Meanwhile, supplier consolidation was witnessed as a strategic move to ensure steady raw material availability.
2025-2029
In this period, a shift towards personalized healthcare is likely to bring changes in the topical skin adhesives market. As buyers, healthcare providers will seek innovative products that cater to specific patient demographics or surgical procedures. Biocompatible adhesives capable of drug delivery may emerge as a crucial buying factor. Manufacturers are likely to adapt by increasing their research and development efforts while seeking strategic partnerships for specialized product lines. A shifting regulatory scenario with increased focus on patient safety can be anticipated, which may demand a robust quality management system. To address potential supply chain disruptions, firms might consider digital solutions for improved visibility and resilience.
2030-2034
By 2030–2034, the market may evolve to reflect advancements in medical technology. Decentralized healthcare models may dominate, driving demand for user-friendly adhesive products. The role of artificial intelligence in predicting demand, ensuring quality and optimizing supply chain might become indispensable. This will likely drive manufacturers for investing in technology-based solutions. In terms of regulation, a move toward global harmonization of requirements can be expected, rose by increasingly cross-border nature of business. Demand for green and sustainable manufacturing practices will likely emerge as a strong factor in procurement decisions. However, the shift towards digital functionalities and greener operations would require companies to pivot their traditional strategies and adopt a more future-oriented business approach.

Future Market Outlook

Future Opportunities

The market indicates promising opportunities driven by shifting customer demands and regulatory requirements. An increasing number of healthcare facilities are seeking localized manufacturing solutions to shorten supply chains and minimize disruptions. This trend invites investment in regional production units, especially in emerging markets across Asia-Pacific and Latin America. Additionally, regulatory bodies are focusing the importance of biocompatibility, offering opportunities for manufacturers that can meet these evolving standards. Companies can capitalize on the growing demand for customizable adhesive solutions tailored to specific medical applications, especially in the wound care sector. The partnership between OEMs and contract manufacturers can also adoption innovation in product development. Moreover, an increase in outpatient and home healthcare practices is creating a demand for user-friendly adhesive applications that patients can easily manage on their own. As healthcare providers aim to enhance patient compliance, there is potential for innovative adhesives that allow for longer wear times and easier removal. Implementing lifecycle management services will also be crucial, as customers seek durable and reliable solutions.

Segmentation Analysis

By Chemistry

The market is segmented by Chemistry into 2-Octyl Cyanoacrylate, N-Butyl Cyanoacrylate, and Others. In 2024, 2-Octyl Cyanoacrylate accounted for the largest revenue share, while N-Butyl Cyanoacrylate is projected to register the fastest CAGR during the forecast period.

Largest Revenue Share

2-Octyl Cyanoacrylate

Market Share Leader

2-Octyl Cyanoacrylate held the largest share of the market. Majorly influenced by its enhanced performance characteristics and versatility in a wide range of applications. Customers witnessed this subsegment favorably due to its reliable efficacy and long shelf life. 2-Octyl Cyanoacrylate also offered factors including a low switching cost, encouraging businesses to continuously choose this subsegment. With seamlessly integrate with the existing infrastructure and workflow of the customers,. Its compliance with regulatory standards and qualifications also boosted its adoption as it facilitated smoother procurement processes. The mature distribution channels and robust service networks for 2-Octyl Cyanoacrylate have adopted its market penetration further, ensuring a consistent supply to cater to the strong replacement demand.

Fastest CAGR

N-Butyl Cyanoacrylate

Forecast Period Growth Leader

N-Butyl Cyanoacrylate is forecasted to grow at the fastest rate due to various market-specific shifts. These changes include emerging customer demand for efficient adhesion solutions, improvements in the performance of N-Butyl Cyanoacrylate, and its commercialization progress. Our examination suggests a trend toward greater acceptability of this subsegment due to its operational efficacy combined with an expanding customer base, changing their purchasing behavior favorably towards N-Butyl Cyanoacrylate. New manufacturing capabilities and an expanded distribution network will also allow for a wider reach. As a result, an increased rate of adoption might be anticipated, thereby accelerating its growth. Toward the later part of the forecast period, ongoing regulatory developments are likely to reduce the barriers to its implementation.

By Application

The report market is segmented by application into Surgical Incisions and Traumatic Lacerations. In 2024, Surgical Incisions accounted for the largest revenue share, while Traumatic Lacerations segment is forecasted to register the fastest CAGR during the forecast period.

Largest Revenue Share

Surgical Incisions

Market Share Leader

Surgical Incisions segment considerably dominated the market by revenue. This recognition is primarily due to its widespread customer adoption, supported by its long-standing presence in clinical environment. Surgical procedures are recurring events in hospitals worldwide, thereby ensuring a consistent demand for applications relevant to surgical incisions. This recurring demand, reinforced by the environment of these applications, further strengthens the purchasing frequency. Furthermore, the well-established and mature distribution channels of surgical supplies, combined with a clear regulatory acceptance for surgical incision related procedures and products, contribute to the revenue leadership position of this subsegment. In terms of supply, availability, and commercial accessibility of products for surgical incisions are high, due to the well established manufacturing capacities of industry stakeholders.

Fastest CAGR

Traumatic Lacerations

Forecast Period Growth Leader

The Traumatic Lacerations subsegment is poised to grow at the fastest rate during the forecasting period. The emerging demand for trauma care advancements is set to boost the revenue of the subsegment. Commercially, the relatively lower current penetration rate of this subsegment provides it with larger scope for growth. However, with improvements in emergency care services, combined with an increased frequency of accidents and trauma globally. Organizations are now recognizing these demands and improving their capabilities, adapting advanced technologies into trauma care. Regulatory changes to encourage better wound treatments are also evident, paving the way for the development of the Traumatic Lacerations market. Manufacturers are innovating in terms of product differentiation, creating deployment flexibility for an increasingly wide range of traumatic lacerations.

By Product Form

The market is segmented by By Product Form into Liquid and Gel. The Liquid segment accounted for the largest revenue share in 2024, while the Gel segment is expected to record the fastest CAGR during the forecast period.

Largest Revenue Share

Liquid

Market Share Leader

Liquid segment was the revenue leader in the market. This dominance was attributed to its broader market acceptance due to well-established implementation in various use cases and customer workflows. The operational benefits offered by liquids, such as ease of application and handling, provided it an enduring edge over the Gel segment. Liquids were also widely compatible with existing infrastructure, leading to easier adoption by customer groups. With a mature distribution network, liquids were readily available and served to the recurrent purchasing behavior characteristic to this market. Regulatory acceptance further solidified its position, eliminating any qualms about its adoption. Furthermore, liquids had a larger installed base due to their earlier commercial availability and deployment maturity.

Fastest CAGR

Gel

Forecast Period Growth Leader

Gel segment is expected to record the fastest CAGR during the forecast period. This is based on the anticipated commercial evolution within the market. Factors such as the emerging customer demand for gel-based products and the evolution in purchasing behavior are expected to drive growth. Gels offer distinctive properties, like enhanced stability and longer performance life, which are gradually being recognized by industry operators, consequently driving demand. Improvements in technology are likely to fuel commercialization of gels, further accelerating its growth. Moreover, prospective regulatory developments are expected to boost this subsegment.

By Distribution Channel

The market is segmented by distribution channel into Direct Sales and Distributors. Distributors accounted for the largest revenue share in 2024, while Direct Sales is expected to register the fastest CAGR during the forecast period.

Largest Revenue Share

Distributors

Market Share Leader

Distributors accounted for the largest revenue share within the market. The distributor model's broad reach attributed to this, as it provides access to a large installed customer base across diverse regions. Distributors have mature supply chains, capable of delivering throughout their market regions, thus ensuring market penetration and consistent revenue streams. Moreover, distributors significantly offer customer support services, supporting customer engagement and promoting repeat business. Broad market adoption is driven by distributors providing a range of options, often accommodating various customer preferences and demands. Distributors, with their extensive networks, contribute to localization, thereby meeting specific regional regulatory and certification requirements.

Fastest CAGR

Direct Sales

Forecast Period Growth Leader

Direct Sales is projected to register the fastest CAGR during the forecast period. The subsegment's growth is driven by several factors. Direct sales allow businesses to engage directly with customers, allowing for a more personalized sales approach that can adopt strong customer relationships. This is a key element in the evolving purchasing behavior where customers value personalized experiences. Technology advancements that allows efficient online direct sales platforms for contributing to the growth of subsegment. Commercialization growth, especially in the digital space, opens new avenues for direct sales, particularly in sectors where customers prefer direct interaction with the product or service provider. The subsegment is likely to benefit from lower implementation barriers, considering that businesses don't need to share their margins with intermediaries, making direct sales a more commercially attractive channel.

By End User

The market is segmented by End User into Hospitals, Emergency Centers, and Clinics. Hospitals accounted for the largest revenue share in 2024, while Clinics are expected to register the fastest CAGR during the forecast period.

Largest Revenue Share

Hospitals

Market Share Leader

Hospitals held the largest revenue share of the market, mainly due to their broader market adoption and large customer base. Hospitals have complex operational structures and necessitate a high degree of medical care, thereby utilizing diverse range of equipment and services present within the market. Additionally, the purchasing frequency at hospitals is significantly high due to the demand for continual service operations. Hospitals also enjoy regulatory acceptance, strong ecosystem compatibility and qualify to procure high-value goods due to their structured purchasing processes. The vast network of distribution channels to hospitals further ensures a steady supply of products. The cost-effective and quality offerings within this market have created a strong adoption preference among hospitals. Based on the typical commercial structure within this market, this assessment assumes that these are the primary factors that contributed to the dominant revenue share of hospitals.

Fastest CAGR

Clinics

Forecast Period Growth Leader

Clinics are expected to record the fastest CAGR during the forecast period due to several market-specific changes. Notable among these is the emerging demand from clinics due to their increasing preference for more advanced services and products. Supported by regulatory developments and reimbursement expansion, clinics have began to embrace new technology and improve their facilities. This is further facilitated by partnerships aimed at enhancing commercialization progress, promising steady distribution expansion for clinics. Technology improvements have lowered the barriers for adoption, and expanded capacities have developed the ecosystem served for clinics. Clinics are expected to increase procurement as the benefits of more refined models outweigh the conventional practices. In contrast with hospitals, clinics have a smaller customer base but enjoy flexibility in deployment, thereby gaining operational efficiency.

Competitive Analysis

Key Market Players

Manufacturers / OEMs

3M
US
Ethicon (Johnson & Johnson)
US
Adhezion Biomedical
US

Key Suppliers & Raw Materials

BASF
Germany
Henkel
Germany
DowDuPont
US

Distributors, Integrators & Channel Partners

Henry Schein
US
McKesson Corporation
US
Cardinal Health
US

Porter’s Five Forces Analysis

This analysis studies the competitive environment of the Topical Skin Adhesives Market.

Supplier Bargaining Power

Medium

Suppliers have moderate power due to availability of raw materials and competitive suppliers.

Buyer Bargaining Power

High

Buyers hold strong power due to the availability of alternatives and low switching costs.

Threat of Substitutes

High

Numerous substitutes like sutures or staples pose significant threats.

Threat of New Entrants

Low

High development costs and stringent regulations deter potential new entrants.

Competitive Rivalry

High

Numerous established companies delivering similar products spur high competitive rivalry.

Regional Analysis

Geographic market dynamics and growth opportunities across key regions

Global Market Outlook

topical-skin-adhesives-market market regional share

North America

In 2024, the market in North America was shaped by several key dynamics, most notably inclusive of increase in procedure-based medical practices in the United States, Canada, and Mexico. Companies such as 3M and Medtronic held a integral role in market dynamics due to their vigorous efforts for innovating product offerings served towards suporting surgical incisions and wounds, consequently influencing procurement strategies across healthcare environment. The trend towards minimally invasive procedures led to a rise in demand for these adhesives, as physicians sought for alternatives to traditional sutures to reduce patient discomfort and healthcare costs.

Concurrently, the compliance to stringent FDA regulations for product approvals and certifications highlighted manufacturing activities, ensuring supply and quality of adhesives across the market. Efforts towards healthcare digitization resulted in advanced distributor partnerships, accelerating the commercialization of these adhesives in various healthcare facilities. Moreover, the role of government-driven healthcare reimbursement policies played a part in market shaping, making these adhesives more affordable for the masses. A rise in enterprise buying emerged from major care-providing institutions like Mayo Clinic and Johns Hopkins due to their high utility in various healthcare routines. Consequently, the adaptation and market infiltration adjusted the operational workflows and led to increased prominence of the market in North America during the base year.

Asia Pacific

In 2024, the market in Asia Pacific was notably driven by regulatory controls, aging population and rapid urbanization. Key players were mainly from China, India and Japan, riding high on the surge in demand from healthcare and cosmetic industries. Products such as 2-octyl cyanoacrylate and n-butyl-2 cyanoacrylate adhesives drove favorable implementation of models within surgical treatments and wound care. With strict regulations dominating the market, within countries such as China and Australia implemented stringent standards for product certification. These measures triggered investments in research to minimize allergic reactions associated with the usage of these adhesives.

Hospitals, deriving demand from operational workflows requiring quick wound closure. Furthermore, there were significant shifts in the supply chain activities, notably in India where manufacturers and distributors capitalized on the digital platform, thereby enhancing customer accessibility to these adhesives. Shifts in procurement models saw hospitals predominantly turn to domestic manufacturers due to preferential pricing dynamics. Collaborations also played a pivotal role with witnessing Chinese manufacturers partnering with Indonesian distributors for accessing the market. The market dynamics in 2024 highlighted a larger interplay between regulatory controls, partnerships and most importantly, the acceptance of these adhesives in mainstream procedures facilitated by technological implementation.

Europe

In 2024, the European market continued to be influenced by changes related to key manufacturers, customer procurement behavior and regulatory developments, within countries such as Germany, the United Kingdom and France playing significant roles in imposing these shifts. The prominent topical skin adhesive manufacturers, such as Johnson & Johnson and 3M, increased their regional spread by implementing active expansion strategies across distribution and sales channels in these countries to serve to the rising demands of diversified medical procedures. However, hospitals, clinics, and other end-user segments in these regions actively re-structured their purchasing procedures, resulting in a pronounced shift towards group purchasing orders for acquiring these products at competitive prices. This trend further led to a newfound focus on localized manufacturing and supply chain adaptability within this market, as strong demand from professional medical sectors drove the production capacities of many adhesive companies.

Regulatory developments, especially the General Data Protection Regulation (GDPR) applied on personal healthcare data, and the Medical Device Regulation (MDR) dealing with the safety and performance of medical devices, also had a significant impact on the market. All stakeholders, from manufacturers to end-users, were driven to revisit their usage and handling of these medical adhesives. Compliance with these regulations required significant organizational adaptability, which in turn fueled broader market shifts in manufacturing, distribution, and procurement practices across Europe.

Latin America

In 2024, the market in Latin America underwent major shifts, predominantly triggered by significant regulatory shifts and commercial patterns. ANVISA (Brazil) and COFEPRIS (Mexico) introduced more rigorous certification requirements for this specific product segment, triggering a significant reevaluation of operational workflows across the region, primarily by manufacturers and distributors. In Argentina, ANMAT implemented new regulatory standards that necessitated changes in the manufacturing activity of topical skin adhesives, impacting distribution channels within the market. Focus was placed on local manufacturing strategies by governments to decrease import dependence, particularly in countries such as Chile and Peru.

Commercial activity was particularly shaped by major end-use industries adjusting their procurement behavior. Healthcare providers, the main buyer group, showed a trend towards enterprise purchasing from established companies, influenced by the enhanced quality assurance these companies offered. Concurrently, larger suppliers expanded their distributor networks in key markets, i.e., Brazil and Mexico, leveraging regional trade agreements under Mercosur and the Pacific Alliance. This expansion was aimed at better servicing the growing demand from major customer industries including healthcare and consumer goods. These developments in Latin America's Topical Skin Adhesive Market during 2024 were substantially driven by regulatory shifts and commercial tactics that directly impacted the manufacturing and distribution strategies adopted by industry players.

Middle East & Africa

In 2024, the Middle East and Africa's topical skin adhesives market was predominantly shaped by a combination of strong healthcare reforms and increased product awareness across countries like Saudi Arabia and South Africa. Proactive measures by the Saudi Food and Drug Authority (SFDA) in the adoption of higher quality standards notably encouraged the utilization of topical skin adhesives in surgical and wound treatment procedures. Similarly, the South African Health Products Regulatory Authority's endorsement of these products created an acceleration in their usage, fostering an increasingly competitive market environment. Noteworthy was the influence of the Dubai Health Authority's customer-centric procurement behaviors, leading to an uptake of advanced topical skin adhesives with features such as reduced wound contraction and enhanced cosmetic outcomes. This shift supported by medical professionals' growing preference for these adhesives over traditional sutures or staples, established the product as an optimal choice in wound closure post-surgery. The UAE's focused approach towards industrialization, exemplified by Operation 300bn, significantly boosted the local manufacturing and supply of these adhesives, which coupled with robust distribution systems, made them readily available to end-users. The pivotal role of regional distributors enhanced by African Continental Free Trade Area (AfCFTA) inspired cross-border trading, paved the way for burgeoning market opportunities. In essence, 2024 served as a year of amplified adoption and accessibility of topical skin adhesives in the Middle East and Africa, enforced by commendable regulatory impetuses and industry-specific developments.

Recent Industry Developments

Latest market innovations, product launches, and strategic initiatives

November 2025

Chemence Medical, Inc. advanced its Exofin® and Exofin Fusion® high-viscosity 2-octyl cyanoacrylate formulations featuring custom curved applicator tips. The system allows surgeons to rapidly seal long, complex surgical incisions—such as orthopaedic total joint replacements and caesarean sections—with uniform tensile strength.

May 2025

Adhezion Biomedical, LLC Commercialized its FloraSeal microbial skin sealant and SurgiSeal liquid topical skin adhesives. Engineered with $N\text{-}2\text{-butyl cyanoacrylate}$ blends, the formulation polymerizes in under 30 seconds upon contact with skin moisture to deliver a fast, watertight microbial seal.

Frequently Asked Questions